Evidence map›Paper›PMID 42008197›Full record

ArticleMikrochimica acta2026

All-in-one silk-fibroin sustainable high performance electrochemical immunoplatforms: determination of the protein TIM-1 in cancer and allergy scenarios as a case study.

Sara Santiago, Andrea Cabrero-Martín, Verónica Serafín, María Pedrero, Xavier Muñoz-Berbel, Gonzalo Guirado, Ana Montero-Calle, José M Pingarrón, Rodrigo Barderas, Susana Campuzano

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara SantiagoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain. ssanti02@ucm.es.ORCID 0000-0002-1206-1455
Andrea Cabrero-MartínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain.ORCID 0009-0001-0785-1495
Verónica SerafínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain.ORCID 0000-0003-0034-8456
María PedreroDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain.ORCID 0000-0002-2047-396X
Xavier Muñoz-BerbelInstituto de Microelectrónica de Barcelona (IMB-CNM, CSIC), Campus UAB, Bellaterra, Spain.ORCID 0000-0002-6447-5756
Gonzalo GuiradoUniversitat Autònoma de Barcelona, Campus UAB, Bellaterra, Spain.ORCID 0000-0003-2128-7007
Ana Montero-CalleChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, Madrid, 28220, Spain.ORCID 0000-0001-5141-0454
José M PingarrónDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain.ORCID 0000-0003-2271-1383
Rodrigo BarderasChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, Madrid, 28220, Spain.ORCID 0000-0003-3539-7469
Susana CampuzanoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de las Ciencias 2, Madrid, 28040, Spain. susanacr@quim.ucm.es.ORCID 0000-0002-9928-6613

Funding

AES-ISCIII PI20CIII/00019AGAUR/Generalitat de Catalunya 2021 SGR 00052Ministerio de Ciencia e Innovación JDC2022-048757-IMinisterio de Ciencia e Innovación PID2022-136351OB-I00Ministerio de Ciencia e Innovación PID2022-140307OB-I00Ministerio de Ciencia e Innovación PID2022-141293OB-I00Ministerio de Ciencia e Innovación PREP2022-000170
6 · The paper itself

Abstract

Silk fibroin (SF) is a natural biopolymer extracted from Bombyx mori that has emerged as a promising sustainable material in biosensing applications, especially because of its biodegradable and tunable properties. However, SF is still insufficiently explored in electrochemical biosensing. We present a novel all-in-one electrochemical immunoplatform based on a disposable electrode surface sequentially modified with Prussian Blue (PB) and SF. First, PB is electrodeposited, acting as a redox mediator that enhances signal amplification through its reversible electrochemistry and its low reduction potential for H2O2. The SF layer is here presented as a novel, biocompatible matrix for antibody immobilization that offers structural versatility and sustainability. This dual modification generates a synergistic ecofriendly functional interface that is stable at room temperature. Onto this innovative surface, we have developed a sandwich-type electrochemical immunosensor employing a biotinylated detector antibody and streptavidin–horseradish peroxidase (Strep-HRP) as the enzymatic label for the determination of T-cell immunoglobulin and mucin-domain containing protein 1 (TIM-1, also known as KIM-1 or HAVCR1), a relevant biomarker associated with cancer-related angiogenesis and poor prognosis, and, more recently, with allergenic episodes. The platform enabled sensitive and selective determination of TIM-1 in plasma samples from colorectal cancer (CRC) patients, and saliva samples from individuals undergoing allergic episodes, in which elevated TIM-1 levels were observed. A remarkable advantage of this immunosensor is its operational stability for up to 20 days at room temperature, eliminating the need for a cold chain.

Indexed as

Biosensing TechniquesElectrochemical TechniquesFibroinsHepatitis A Virus Cellular Receptor 1NeoplasmsAnimalsAntibodies, ImmobilizedBombyxElectrodesFerrocyanidesHumansImmunoassayLimit of DetectionAntibodies, Immobilizedferric ferrocyanideFerrocyanidesFibroinsHepatitis A Virus Cellular Receptor 1All-in-one electrochemical immunoplatformAmperometric detectionPlasma analysisPrussian blueSalivaSilk fibroin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.